We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hemoglobin May Be Toxic for the Diseased Liver

By HospiMedica International staff writers
Posted on 13 May 2013
A new study suggests that high levels of hemoglobin may be dangerous in patients with nonalcoholic fatty liver disease (NAFLD), with bleeding a potential remedy. More...


Researchers at the University of Milan (Italy) conducted an open-label, randomized study involving 38 NAFLD patients with iron overload—defined as serum ferritin higher than 250 mg/mL—or on the basis of liver histological analysis and blood hemoglobin of more than 11 g/dL. The patients were randomized to an iron-directed treatment or phlebotomy every two weeks, with 350 mL of blood taken at each session until serum ferritin declined to less than 100 mg/mL, and transferrin saturation was in the range of 40%–50%. All patients also underwent lifestyle counseling.

The results showed that at the 2-year evaluation, mean ferritin levels stood at 600 mg/mL in the control group, compared with less than 200 mg/mL in the phlebotomy arm. Similarly, mean transferrin saturation was 38% in controls, versus 28% in the phlebotomy group; at baseline, both groups had averages close to 40%. Both groups had dips in mean alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels at the 6-month mark. However, while levels plateaued or increased in the control group at subsequent evaluations, they further declined in the phlebotomy group. The study was presented at the European Association for the Study of the Liver (EASL) annual conference, held during April 2013 in Amsterdam (The Netherlands).

“Control patients showed slight average declines from baseline in serum ferritin and transferrin saturation, whereas those undergoing phlebotomy had markedly steeper reductions,” concluded lead author and study presenter Luca Valenti, MD. “Histologic analysis of liver biopsy samples indicated that 33% of the phlebotomy patients and 11% of the controls had improvements from baseline during the study period.”

Phlebotomy, or bloodletting, is the withdrawal of often small quantities of blood from a patient to cure or prevent illness and disease. Bloodletting was based on an ancient system of medicine in which blood and other bodily fluid were regarded as "humors" that had to remain in proper balance to maintain health. It was the most common medical practice performed by physicians from antiquity until the late 19th century, a span of almost 2,000 years. The practice has now been abandoned for all except a few very specific conditions such as hemochromatosis, polycythemia vera, porphyria cutanea tarda, etc., to reduce the amount of red blood cells.

Related Links:
University of Milan



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.